Molnutaj 200 Capsules, manufactured by Taj Pharmaceuticals Ltd, is a prescription medication specifically developed for the treatment of mild-to-moderate coronavirus disease (COVID-19) in adults. It is designed for individuals who have tested positive for SARS-CoV-2 virus and are at high risk for progressing to severe COVID-19, including hospitalization or death. Molnutaj 200 offers a viable treatment option for those who do not have access to or cannot use alternative FDA-authorized COVID-19 treatments.

Molnutaj 200 contains the active ingredient Molnupiravir, which has shown promising results in combating the effects of COVID-19. This medication should be initiated as soon as possible after a diagnosis of COVID-19 and within five days of symptom onset. With its antiviral properties, Molnutaj 200 aims to reduce the viral load in the body and help mitigate the severity of the illness.

Taj Pharmaceuticals Ltd, a reputable pharmaceutical company based in India, adheres to stringent quality standards during the manufacturing process of Molnutaj 200. We are committed to producing safe and effective medications ensures that patients receive a reliable treatment option for managing COVID-19 symptoms.